Suppr超能文献

印度次喜马拉雅地区内脏利什曼病(1967-2023):系统评价。

Visceral Leishmaniasis in Sub-Himalayan India (1967-2023): A Systematic Review.

机构信息

Department of Medical Parasitology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Center for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

出版信息

Am J Trop Med Hyg. 2024 Aug 27;111(5):928-933. doi: 10.4269/ajtmh.24-0036. Print 2024 Nov 6.

Abstract

Substantial gains have been achieved in the control of visceral leishmaniasis (VL) in the four endemic states of India; however, cases are sporadically reported from other nonendemic regions of India such as the sub-Himalayan region, which can be a hurdle to VL elimination. We analyzed VL reports published from the sub-Himalayan regions of India over seven decades (1967-2023) in this systematic review. Medline, Embase, Scopus, and Web of Science were searched for VL cases from sub-Himalayan regions of India. The demographic data, clinical presentation, diagnostic modality, treatment, outcomes of the cases, and overall year-wise and geographical distribution of the cases were analyzed; studies on the sand fly vector were also included. From 535 articles, 33 studies were included in the analysis. Overall, 228 patients were diagnosed with VL in the sub-Himalayan region of India from 1967 to 2023. These cases were reported from Uttarakhand (n = 178), Himachal Pradesh (n = 39), and Jammu and Kashmir (n = 11). Most patients (88.4%) did not have a history of travel outside their native places. Three pediatric cases were reported from Jammu and Kashmir. The DNA of Leishmania donovani was detected in four of the 52 (7.7%) sand flies collected from Himachal Pradesh. The published literature points toward the existence of local transmission of VL in the sub-Himalayan region of India, strongly substantiated by the emergence of pediatric VL in some places. Thus, these difficult-to-reach hilly states of India will require focused surveillance for VL to successfully achieve elimination goals.

摘要

印度四个流行内脏利什曼病(VL)的邦已经取得了显著进展;然而,在印度其他非流行地区,如喜马拉雅山脉下地区,也有零星报告病例,这可能是消除 VL 的一个障碍。我们在本系统评价中分析了印度喜马拉雅山脉下地区 70 多年(1967-2023 年)发表的 VL 报告。我们在 Medline、Embase、Scopus 和 Web of Science 上搜索了来自印度喜马拉雅山脉下地区的 VL 病例。分析了病例的人口统计学数据、临床表现、诊断方式、治疗、病例结局以及病例的总体年度和地理分布;还包括对沙蝇媒介的研究。从 535 篇文章中,有 33 项研究纳入了分析。总体而言,从 1967 年到 2023 年,印度喜马拉雅山脉下地区共诊断出 228 例 VL 病例。这些病例来自北阿坎德邦(n=178)、喜马偕尔邦(n=39)和查谟和克什米尔邦(n=11)。大多数患者(88.4%)没有在当地以外旅行的病史。有 3 例儿科病例来自查谟和克什米尔。从喜马偕尔邦采集的 52 只沙蝇中,有 4 只(7.7%)检测到利什曼原虫 DNA。已发表的文献表明,印度喜马拉雅山脉下地区存在 VL 的本地传播,某些地方出现儿科 VL 病例进一步证实了这一点。因此,印度这些难以到达的丘陵州将需要对 VL 进行重点监测,以成功实现消除目标。

相似文献

2
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

2
Visceral leishmaniasis outbreak in Kenya-a setback to the elimination efforts.肯尼亚内脏利什曼病疫情——消除工作的挫折
New Microbes New Infect. 2022 Nov 29;49-50:101060. doi: 10.1016/j.nmni.2022.101060. eCollection 2022 Nov-Dec.
8
Epidemiology of Post-Kala-azar Dermal Leishmaniasis.黑热病后皮肤利什曼病的流行病学
Indian J Dermatol. 2021 Jan-Feb;66(1):12-23. doi: 10.4103/ijd.IJD_651_20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验